We've found
6,666
archived clinical trials in
Hospital
We've found
6,666
archived clinical trials in
Hospital
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Updated: 8/29/2017
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Updated: 8/29/2017
Acute Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Status: Enrolling
Updated: 8/29/2017
Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Updated: 8/29/2017
Acute Effects of Exercise on Memory in Healthy and Brain-Injured Individuals
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Updated: 8/30/2017
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated: 8/30/2017
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Updated: 8/30/2017
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated: 8/30/2017
Click here to add this to my saved trials
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Updated: 8/30/2017
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated: 8/30/2017
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Updated: 8/30/2017
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated: 8/30/2017
Click here to add this to my saved trials
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
Updated: 8/31/2017
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Status: Enrolling
Updated: 8/31/2017
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
Updated: 8/31/2017
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Updated: 8/31/2017
A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury
Status: Enrolling
Updated: 8/31/2017
Click here to add this to my saved trials
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Updated: 9/5/2017
RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Status: Enrolling
Updated: 9/5/2017
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Updated: 9/5/2017
RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Updated: 9/5/2017
RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Status: Enrolling
Updated: 9/5/2017
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Updated: 9/5/2017
RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Updated: 9/5/2017
RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Status: Enrolling
Updated: 9/5/2017
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Updated: 9/5/2017
RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Updated: 9/6/2017
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
Status: Enrolling
Updated: 9/6/2017
Click here to add this to my saved trials
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Updated: 9/7/2017
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Status: Enrolling
Updated: 9/7/2017
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Updated: 9/7/2017
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Safety of Riluzole in Patients With Acute Spinal Cord Injury
Updated: 9/11/2017
Safety and Pharmacokinetics of Riluzole in Patients With Traumatic Acute Spinal Cord Injury
Status: Enrolling
Updated: 9/11/2017
Safety of Riluzole in Patients With Acute Spinal Cord Injury
Updated: 9/11/2017
Safety and Pharmacokinetics of Riluzole in Patients With Traumatic Acute Spinal Cord Injury
Status: Enrolling
Updated: 9/11/2017
Click here to add this to my saved trials
Safety of Riluzole in Patients With Acute Spinal Cord Injury
Updated: 9/11/2017
Safety and Pharmacokinetics of Riluzole in Patients With Traumatic Acute Spinal Cord Injury
Status: Enrolling
Updated: 9/11/2017
Safety of Riluzole in Patients With Acute Spinal Cord Injury
Updated: 9/11/2017
Safety and Pharmacokinetics of Riluzole in Patients With Traumatic Acute Spinal Cord Injury
Status: Enrolling
Updated: 9/11/2017
Click here to add this to my saved trials